Lean mass as a determinant of bone mineral density of proximal femur in postmenopausal women by Rosangela Villa Marin-Mio (5834441)

<b>Human disturbance alters the foraging and spatiotemporal activity of a large carnivore</b> by Gonzalo Barceló (10117075)

Is a sequence of tests during urethral pressure profilometry correlated with symptoms assessment in women? by Françoise A. Valentini (12832132)

Factors associated with postoperative signs and symptoms in teeth with periapical lesion: a longitudinal study by Erlange Andrade Borges Silva (14224193)

EFFECTS OF A PSYCHOLOGICAL SKILL TRAINING PROGRAM ON ANXIETY LEVELS IN TOP KARATE ATHLETES by Ana Vesković (7476821)

Effect of atenolol pre-treatment in heart damage in a model of intestinal ischemia-reperfusion by Mieko Okada (4696906)

Crystal structure and cytotoxic activities of a bis(pyrrolyl-imine) gold(III) complex by Daniel De Moraes Profirio (2885411)

Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

“…<p><i>PELP1</i>-KD/SMIP34 treatment decreased cell viability, clonogenicity, and invasiveness of HCC cells. …”

Image_1_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

“…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”

Table_1_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

“…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”

Image_3_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

“…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”

Image_2_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

“…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”

Image_4_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

“…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”

The improved network structure of YOLOv7-tiny. by Yulu Zhang (1774471)

“…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”

Salmon thrombin reduces spinal neuronal hyperexcitability after a painful root compression in the rat. by Jenell R. Smith (487736)

“…(<b>C</b>) Overall, salmon thrombin (STh) produces a significant decrease in the number of evoked spikes compared to both neurobasal media (NB media) (p = 0.002) and human thrombin (HTh) treatment (p<0.001). …”

Growth and B12 uptake of <i>C. reinhardtii</i> metE7 in axenic cultures containing <i>7.5×10⁻¹⁴ mol</i>/<i>mL</i> B12 (i.e. <i>100 ng</i>/<i>L</i>). by Hannah Laeverenz Schlogelhofer (10834313)

“…<p>(A) Growth of <i>C</i>. <i>reinhardtii</i> metE7 in Tris minimal medium + 7.5×10⁻¹⁴ <i>mol</i>/<i>mL</i> B₁₂ measured by counting cell density using a Z2 particle count analyser (Beckman Coulter Ltd). …”

Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”

Data Sheet 2_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”

Data Sheet 3_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”

Data Sheet 4_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”